Cistus incanus

Cistus incanus is a Mediterranean shrub rich in polyphenolic compounds, particularly monomeric and oligomeric proanthocyanidins and catechins, which drive its antioxidant and antimicrobial properties. Its primary mechanisms involve free radical scavenging and disruption of bacterial cell membrane integrity, with traditional use recognized by the European Medicines Agency for respiratory tract support.

Origin & History

Cistus incanus (pink rock-rose) is a perennial shrub native to the Mediterranean region, particularly Crete, belonging to the Cistaceae family. The herbal substance is derived from its aerial parts harvested during flowering and prepared as comminuted material for herbal tea via decoction. It contains polyphenolic compounds including flavonoids and tannins as its primary bioactive constituents.

Historical & Cultural Context

Cistus creticus herba has traditional use in European Mediterranean herbal medicine systems for treating cough and cold symptoms. This traditional application was formally assessed by EMA/HMPC under Article 16d(1) of Directive 2001/83/EC and finalized on 28/01/2014.

Health Benefits

• Traditional respiratory support for cough and cold symptoms (Traditional use only - EMA/HMPC assessment)
• In vitro antibacterial activity against Gram-positive bacteria including S. aureus and MRSA (MIC 4 mg/mL) (Laboratory evidence only)
• Potential anti-inflammatory effects through suppression of IL-6 and COX-2 mRNA expression (In vitro evidence only)
• Antioxidant pathway activation via Nrf2 nuclear translocation and HO-1 expression upregulation (In vitro evidence only)
• No significant effect on human oxidative stress markers in 3-month supplementation study (MDA and AOPP unchanged)

How It Works

The polyphenols in Cistus incanus, including myricetin, kaempferol, and proanthocyanidins, inhibit NF-κB signaling pathways, thereby suppressing downstream pro-inflammatory cytokine production including TNF-α and IL-6. Its antibacterial activity against Gram-positive organisms such as S. aureus and MRSA operates through disruption of bacterial lipid membrane integrity and inhibition of cell wall biosynthesis, with reported minimum inhibitory concentrations around 4 mg/mL in vitro. Additional antioxidant effects are mediated by direct superoxide and hydroxyl radical scavenging via the hydroxyl groups on its flavonoid backbone.

Scientific Research

Clinical evidence is limited to one 3-month human supplementation study showing no significant changes in oxidative stress markers (MDA 15±4.9 vs 15±4.5 μmol/L; AOPP 53±17 vs 54±16 μmol/L). No large-scale RCTs, meta-analyses, or PubMed PMIDs were identified in the available research. Most evidence comes from in vitro studies demonstrating antibacterial and anti-inflammatory properties.

Clinical Summary

The European Medicines Agency's HMPC has granted Cistus incanus a traditional use monograph for symptomatic relief of mild upper respiratory tract irritation, though this designation is based on historical use data rather than controlled clinical trials. Published in vitro studies demonstrate antibacterial activity against S. aureus and MRSA at MIC values of approximately 4 mg/mL, but these findings have not been replicated in adequately powered human randomized controlled trials. One small pilot study examined Cistus incanus extract in the context of influenza-like illness, reporting reduced symptom duration, but the study lacked sufficient sample size and blinding rigor to support definitive conclusions. Overall, the clinical evidence base remains preliminary, and efficacy in humans for infection management or inflammation has not been established to regulatory standards.

Nutritional Profile

Cistus incanus is consumed primarily as an herbal tea/tisane rather than a significant source of macronutrients or micronutrients. Macronutrient contribution from typical tea preparation is negligible (dried leaf/aerial parts yield <1g protein, <0.5g carbohydrates, and trace lipids per standard 2g tea serving). The nutritional significance lies almost entirely in its polyphenolic bioactive fraction. Key bioactive compounds include: (1) Polyphenols at exceptionally high concentrations — total polyphenol content reported at 40–65% dry weight of aerial parts, among the highest recorded for any European medicinal plant; (2) Proanthocyanidins (condensed tannins) — predominant fraction, estimated 15–30% dry weight, primarily catechin and epicatechin oligomers and polymers, responsible for astringency and much of the antioxidant and antimicrobial activity; (3) Monomeric flavan-3-ols including (+)-catechin and (-)-epicatechin; (4) Flavonols — kaempferol, quercetin, and myricetin glycosides detected in leaf extracts; (5) Labdane-type diterpenes (labdanolic acid, cistusdiol) concentrated in leaf resin glands; (6) Phenolic acids including gallic acid, ellagic acid, and caffeic acid derivatives; (7) Volatile terpenes including camphene, α-pinene, and borneol in essential oil fraction (<0.1% of dry weight). Mineral content of the whole dried herb includes trace amounts of calcium, magnesium, potassium, and iron, but these are not nutritionally meaningful at typical herbal tea doses. Bioavailability notes: Proanthocyanidins have limited gastrointestinal absorption due to high molecular weight polymers; monomeric catechins are more bioavailable with estimated intestinal absorption of 20–30%. Tannin content may reduce iron bioavailability from co-consumed foods if taken with meals. Aqueous tea infusion (standard preparation) extracts primarily water-soluble polyphenols and phenolic acids; lipophilic diterpenes are poorly extracted in hot water and remain largely in spent plant material.

Preparation & Dosage

Clinically studied as daily herbal tea infusion following commercial product instructions (exact dosage unspecified, yielding MIC 4 mg/mL infusions). EMA draft monograph recommends comminuted herba as herbal tea (decoction) for oral use without specific quantified dosage ranges. No data available on powder or standardized extract forms. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Echinacea, Elderberry, Vitamin C, Zinc, Propolis

Safety & Interactions

Cistus incanus is generally considered well tolerated at typical herbal tea or standardized extract doses, with no serious adverse events reported in traditional use literature reviewed by the EMA. Due to its significant polyphenol content, there is a theoretical risk of interaction with iron absorption; it should not be consumed simultaneously with iron supplements or iron-rich meals. No adequately studied drug interactions exist in the clinical literature, but caution is warranted with anticoagulants such as warfarin, as high-dose polyphenols may affect platelet aggregation. Safety during pregnancy and breastfeeding has not been established, and use is not recommended in these populations per the EMA traditional use monograph.